PALI
PALISADE BIO, INC.
Key Financials
EPS (Diluted)
$-0.30
↑ 97.1%
Total Assets
$134.3M
↑ 1134.8%
Revenue
$0
↓ 100.0%
Operating Income
$-18056000
↓ 21.5%
Net Income
$-16781000
↓ 16.2%
Cash & Equivalents
$133.4M
↑ 1258.2%
Total Liabilities
$5.0M
↑ 46.5%
Shareholders' Equity
$129.4M
↑ 1626.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/18/2026 | View on SEC |
| 3 | 6/18/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 3 | 6/12/2026 | View on SEC |
| 8-K | 6/11/2026 | View on SEC |
| S-8 | 6/10/2026 | View on SEC |
| SCHEDULE 13G | 5/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PALI |
| Company Name | PALISADE BIO, INC. |
| CIK | 1357459 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (858) 704-4900 |